Greater abdominal aortic calcification ups dementia risk in older women

Older women with more advanced abdominal aortic calcification (AAC) have a higher risk for late-life dementia, according to a study published online June 26 inThe Lancet Regional Health: Western

Updated on: May 13,2024

Greater abdominal aortic calcification ups dementia risk in older women

Older women with more advanced abdominal aortic calcification (AAC) have a higher risk for late-life dementia, according to a study published online June 26 inThe Lancet Regional Health: Western

Updated on:May 13,2024

Transcranial direct current stimulation found to be safe, effective for tardive dyskinesia

by Lori SolomonTranscranial direct current stimulation (tDCS) may be an effective and safe treatment for improving the facial-oral motor symptoms of tardive dyskinesia (TD) in chronically hospitalized

Updated on: November 27,2024

Transcranial direct current stimulation found to be safe, effective for tardive dyskinesia

by Lori SolomonTranscranial direct current stimulation (tDCS) may be an effective and safe treatment for improving the facial-oral motor symptoms of tardive dyskinesia (TD) in chronically hospitalized

Updated on:November 27,2024

Research holds promise for Alzheimer's diagnostic blood test

by University of OtagoUniversity of Otago researchers have discovered a promising new marker that could help diagnose Alzheimer's disease—and all that might be required is a simple blood test

Updated on: February 28,2024

Research holds promise for Alzheimer's diagnostic blood test

by University of OtagoUniversity of Otago researchers have discovered a promising new marker that could help diagnose Alzheimer's disease—and all that might be required is a simple blood test

Updated on:February 28,2024

Signs of Alzheimer's disease may be detectable before significant symptoms are obvious

by University of GlasgowCredit: Pixabay/CC0 Public DomainHealthy people with a higher genetic risk of Alzheimer's disease may show differences in brain structure and in cognitive test scores

Updated on: April 08,2024

Signs of Alzheimer's disease may be detectable before significant symptoms are obvious

by University of GlasgowCredit: Pixabay/CC0 Public DomainHealthy people with a higher genetic risk of Alzheimer's disease may show differences in brain structure and in cognitive test scores

Updated on:April 08,2024

A 'chemical metronome': Researchers uncover how astrocytes help the brain's master clock keep time

by Ryan O'Hare,Imperial College LondonCharacterization of phase relationship between Syn-jRCaMP1a and Syn-GABASnFR and theirsynchronization across the SCN network and single cells. Cre

Updated on: December 17,2024

A 'chemical metronome': Researchers uncover how astrocytes help the brain's master clock keep time

by Ryan O'Hare,Imperial College LondonCharacterization of phase relationship between Syn-jRCaMP1a and Syn-GABASnFR and theirsynchronization across the SCN network and single cells. Cre

Updated on:December 17,2024

Research to tackle the triple challenge of dementia, hearing and vision impairment

by University of ManchesterThe combined impact of dementia, age-related hearing and vision impairment is to be investigated by a new multi-million European research consortium led by The Universi

Updated on: February 28,2024

Research to tackle the triple challenge of dementia, hearing and vision impairment

by University of ManchesterThe combined impact of dementia, age-related hearing and vision impairment is to be investigated by a new multi-million European research consortium led by The Universi

Updated on:February 28,2024

New indication of a link between Alzheimer's and diabetes

by Forschungszentrum JuelichIllustration of IAPP fibrils. Credit: Forschungszentrum Jülich/HHU Düsseldorf/Gunnar SchröderPathological protein clumps are characteristic of a series of diseases, su

Updated on: April 10,2024

New indication of a link between Alzheimer's and diabetes

by Forschungszentrum JuelichIllustration of IAPP fibrils. Credit: Forschungszentrum Jülich/HHU Düsseldorf/Gunnar SchröderPathological protein clumps are characteristic of a series of diseases, su

Updated on:April 10,2024

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on: April 16,2024

Alzheimer's drug gantenerumab fails to slow decline in phase III clinical trial

by Alzheimer's Research UKCredit: Pixabay/CC0 Public DomainThe pharmaceutical company Roche has announced that two phase III trials of the potential Alzheimer's drug gantenerumab did not

Updated on:April 16,2024

How inflammation alters nerve cell responses to make touch painful

Updated on: May 15,2025

How inflammation alters nerve cell responses to make touch painful

Updated on:May 15,2025

How Alzheimer's disease spreads throughout the brain – new study

by Thomas E Cope,The ConversationHarmful tau protein spreads through networks.Alzheimer's disease is a devastating brain illness that affects anestimated 47m peopleworldwide. It

Updated on: April 10,2024

How Alzheimer's disease spreads throughout the brain – new study

by Thomas E Cope,The ConversationHarmful tau protein spreads through networks.Alzheimer's disease is a devastating brain illness that affects anestimated 47m peopleworldwide. It

Updated on:April 10,2024

FDA panel reviews 1st new Alzheimer's drug in 2 decades

by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca

Updated on: March 30,2024

FDA panel reviews 1st new Alzheimer's drug in 2 decades

by Marilynn Marchione and Matthew PerroneIn this Dec. 12, 2019 photo provided by Biogen, a scientist works on Alzheimer's disease research in a laboratory at the drugmaker's headquarters in Ca

Updated on:March 30,2024

FDA approves much-debated Alzheimer's drug panned by experts

by Matthew PerroneIn this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administratio

Updated on: March 30,2024

FDA approves much-debated Alzheimer's drug panned by experts

by Matthew PerroneIn this 2019 photo provided by Biogen, a researcher works on the development of the medication aducanumab in Cambridge, Mass. On Monday, June 7, 2021, the Food and Drug Administratio

Updated on:March 30,2024